Zobrazeno 1 - 10
of 14
pro vyhledávání: '"T H Fischer"'
Publikováno v:
European Heart Journal. 39
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bc043eb63e834cbd72b8721c97d9b91
https://doi.org/10.1093/eurheartj/ehy565.p1888
https://doi.org/10.1093/eurheartj/ehy565.p1888
Autor:
T. H. Fischer, T. Ruppert, Carr J. Smith, David J. Doolittle, Gerhard Scherer, Walter T. Morgan
Publikováno v:
Inhalation Toxicology. 10:431-441
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b70352df922b626536a069e7b08f8b90
https://doi.org/10.1080/089583798197619
https://doi.org/10.1080/089583798197619
Publikováno v:
International Journal of Quantum Chemistry. 45:679-688
Third-order optimization methods that require the evaluation of the gradient and initial estimates for the second and third derivatives are described. Update algorithms for the Hessian and the third-derivative tensor are outlined. The direct inversio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea2a039b9e7c133992d7ffa8ae16561c
https://doi.org/10.1002/qua.560450616
https://doi.org/10.1002/qua.560450616
Publikováno v:
International Journal of Quantum Chemistry. 45:665-678
A program to optimize the structure of large molecules at the Hartree-Fock level of theory running concurrently on a network of workstations is presented. Problems encountered in obtaining nearly optimal speedup and their solutions are discussed. A s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9cd7dc3193cce03c62a0fbb0341fc73d
https://doi.org/10.1002/qua.560450615
https://doi.org/10.1002/qua.560450615
Publikováno v:
Haemophilia. 14:871-872
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7940abf2ecbc86df6bb44dce63488535
https://doi.org/10.1111/j.1365-2516.2008.01771.x
https://doi.org/10.1111/j.1365-2516.2008.01771.x
Publikováno v:
Thrombosis and haemostasis. 79(4)
Platelet membrane glycoproteins (GP) IIb/IIa and rap1b, a 21 kDa GTP binding protein, associate with the triton-insoluble, activation-dependent platelet cytoskeleton with similar rates and divalent cation requirement. To examine the possibility that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6c9063e1cc2501e1f9a80e193f291853
https://pubmed.ncbi.nlm.nih.gov/9569200
https://pubmed.ncbi.nlm.nih.gov/9569200
Publikováno v:
The Journal of biological chemistry. 269(25)
Rap 1b is a 22-kDa low molecular mass GTP-binding protein which is both a member of the Ras superfamily and a substrate for cAMP-dependent protein kinase. Recently, evidence has been presented to show that Rap 1b is incorporated into the detergent-ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::069e0fcb1805cee8da6a89c8feee95b4
https://pubmed.ncbi.nlm.nih.gov/7516336
https://pubmed.ncbi.nlm.nih.gov/7516336
Publikováno v:
Advances in experimental medicine and biology. 344
We have presented evidence that rap1b, a 22 kDa low molecular weight GTP binding protein, becomes associated with the cytoskeleton in thrombin-activated platelets. The initial incorporation is very rapid and occurs as fast as we can measure it. Thus,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::72aaeffbafee88f37d28b4ea40a9eaa0
https://pubmed.ncbi.nlm.nih.gov/8209787
https://pubmed.ncbi.nlm.nih.gov/8209787
Publikováno v:
The Journal of biological chemistry. 265(32)
rap1B is a member of the ras superfamily of low molecular weight GTP binding proteins which constitutes a focal point of GTP and cAMP signal transduction systems. Like other members of this superfamily, rap1B is membrane-associated in resting platele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c1293313db8a3887b7d75a8f6896ef22
https://pubmed.ncbi.nlm.nih.gov/2123187
https://pubmed.ncbi.nlm.nih.gov/2123187
Autor:
Bernd Dörken, U. Heinen, A. D. Ho, T. Zwingers, H. Fuhr, K. Straif, U. Papendick, D. Schuster, H. Gamm, J. Kraft, L. Nowicki, Andreas Neubauer, A. Heyll, U. Essers, H.A. Vaupel, M. Schrappe-Bächer, T.-H. Fischer, H. D. Bruhn, J. Hayungs, D. Asshoff, Arnold Ganser, R. M. Parwaresch, I. Schober, G. Pfannschmidt, K. Bremer, H. D. Schwöbel, A. Bartel, H. Pralle, Karl-Heinz Pflüger, R. Saß, K. Bross, S. Boedewadt-Radzun, N. Drees, A. Vonnegut, W. Schmidt, H. Euler
Publikováno v:
Oncology Research and Treatment. 11:44-47
Die Haarzelleukamie wurde mit α-2-Interferonen nach zwei aufeinander abgestimmten Therapieprotokollen behandelt. Die Wirksamkeit niedriger Tagesdosen konnte belegt werden und ebenso die geringe Rate an Nebenwirkungen. Die niedrigen Dosen verbesserte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4012c160a30af8b3b0ba8b937be08c4
https://doi.org/10.1159/000216481
https://doi.org/10.1159/000216481